These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33890379)

  • 1. Cost-analysis of opportunistic influenza vaccination in general medical inpatients.
    Darmaputra DC; Zaman FY; Khu YL; Nagalingam V; Liew D; Aung AK
    Intern Med J; 2021 Apr; 51(4):591-595. PubMed ID: 33890379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities to improve influenza vaccination rates in general medical inpatients.
    Zaman FY; Nagalingam V; Wong C; Khu YL; Teng HWG; Janardan J; Ritchie E; Cheng AC; Aung AK
    Intern Med J; 2019 May; 49(5):662-665. PubMed ID: 31083800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of influenza vaccination. Assessment for The Netherlands.
    Postma MJ; Bos JM; van Gennep M; Jager JC; Baltussen R; Sprenger MJ
    Pharmacoeconomics; 1999; 16 Suppl 1():33-40. PubMed ID: 10623374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-benefit analysis of a national influenza vaccination program in preventing hospitalisation costs in Australian adults aged 50-64 years old.
    Raj SM; Chughtai AA; Sharma A; Tan TC; MacIntyre CR
    Vaccine; 2019 Sep; 37(40):5979-5985. PubMed ID: 31473001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age.
    Allsup S; Gosney M; Haycox A; Regan M
    Health Technol Assess; 2003; 7(24):iii-x, 1-65. PubMed ID: 14499051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
    Thorrington D; van Leeuwen E; Ramsay M; Pebody R; Baguelin M
    Vaccine; 2019 Apr; 37(15):2051-2056. PubMed ID: 30871927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Low vaccination coverage against influenza in elderly hospitalized in France].
    Rouveix E; Greffe S; Dupont C; Gherissi Cherni D; Beauchet A; Sordet Guepet H; Gavazzi G; Gaillat J;
    Rev Med Interne; 2013 Dec; 34(12):730-4. PubMed ID: 23473715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of influenza vaccine in the elderly.
    Nichol KL; Margolis KL; Wouremna J; von Sternberg T
    Gerontology; 1996; 42(5):274-9. PubMed ID: 8940650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of influenza immunization on pneumonia in the elderly.
    Heo JY; Song JY; Noh JY; Choi MJ; Yoon JG; Lee SN; Cheong HJ; Kim WJ
    Hum Vaccin Immunother; 2018 Mar; 14(3):744-749. PubMed ID: 29135343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
    Wongsurakiat P; Lertakyamanee J; Maranetra KN; Jongriratanakul S; Sangkaew S
    J Med Assoc Thai; 2003 Jun; 86(6):497-508. PubMed ID: 12924797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza in the school-aged population in Mexico: burden of disease and cost-effectiveness of vaccination in children.
    Falcón-Lezama JA; Saucedo-Martínez R; Betancourt-Cravioto M; Alfaro-Cortes MM; Bahena-González RI; Tapia-Conyer R
    BMC Infect Dis; 2020 Mar; 20(1):240. PubMed ID: 32197591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza epidemiology, vaccine coverage and vaccine effectiveness in sentinel Australian hospitals in 2013: the Influenza Complications Alert Network.
    Cheng AC; Dwyer DE; Holmes M; Irving LB; Brown SG; Waterer GW; Korman TM; Hunter C; Hewagama S; Friedman ND; Wark PA; Simpson G; Upham JW; Bowler SD; Senenayake SN; Kotsimbos TC; Kelly PM
    Commun Dis Intell Q Rep; 2014 Jun; 38(2):E143-9. PubMed ID: 25222208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.
    Yang J; Jit M; Leung KS; Zheng YM; Feng LZ; Wang LP; Lau EH; Wu JT; Yu HJ
    Infect Dis Poverty; 2015 Oct; 4():44. PubMed ID: 26445412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    Peasah SK; Meltzer MI; Vu M; Moulia DL; Bridges CB
    PLoS One; 2019; 14(4):e0213499. PubMed ID: 31034485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia.
    de Boer PT; Kelso JK; Halder N; Nguyen TP; Moyes J; Cohen C; Barr IG; Postma MJ; Milne GJ
    Vaccine; 2018 Feb; 36(7):997-1007. PubMed ID: 29373192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling estimates of age-specific influenza-related hospitalisation and mortality in the United Kingdom.
    Matias G; Taylor RJ; Haguinet F; Schuck-Paim C; Lustig RL; Fleming DM
    BMC Public Health; 2016 Jun; 16():481. PubMed ID: 27278794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential economic value of influenza vaccination for healthcare workers in The Netherlands.
    Meijboom MJ; Riphagen-Dalhuisen J; Hak E
    Influenza Other Respir Viruses; 2018 Jul; 12(4):457-464. PubMed ID: 29624882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities.
    You JH; Wong WC; Ip M; Lee NL; Ho SC
    J Epidemiol Community Health; 2009 Nov; 63(11):906-11. PubMed ID: 19608558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of influenza vaccination. A North American perspective.
    Fedson DS
    Pharmacoeconomics; 1996; 9 Suppl 3():54-61. PubMed ID: 10160488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.